Drawing for FECINOR

USPTO serial 79221914

FECINOR

Reviewed by CopyMark Law Group

Reg. 5753865Status 709
Filing date
Status date
Registration date
May 21, 2019
Examiner
PODESTA, GIDETTE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FECINOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; pharmaceutical and veterinary preparations for the prevention and treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and veterinary preparations for the prevention and treatment of necrotic enteritis; diarrhea medication; pharmaceutical and veterinary preparations for the prevention and treatment of intestinal bacteria; pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders containing Enterococcus faecium; veterinary pharmaceutical preparations for the prevention and for the treatment of probiotic deficiencies; veterinary preparations, namely, feeding stimulants for animals; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; medical and veterinary preparations for the prevention and for the treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; medical and veterinary preparations, namely, fodder acidifiers for medical purposes and fodder additives for medical purposes in form of amino acids, peptides and proteins and mixtures thereof; medical and veterinary preparations for the prevention and for the treatment of necrotic enteritis; medical and veterinary preparations for the prevention and for the treatment of intestinal bacteria; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders containing Enterococcus faecium; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of necrotic enteritis; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of intestinal bacteria; amino acids for medical and veterinary purposes; chemical preparations in the nature of esters, medicinal oils and greases for medical and veterinary purposes; salts, in particular potassium and sodium salts for medical purposes; salts, in particular potassium and sodium salts for veterinary medical purposes; steroids; ferments for pharmaceutical purposes; dietetic foods, namely, yeast and starch for medical purposes; yeast and starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; biological preparations for medical and veterinary purposes, namely, for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures; dietetic food and substances adapted for medical or veterinary use; albuminous preparations for medical purposes, namely, albumin dietary supplements; medicated confectionery in the nature of medicated candy; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; protein dietary supplements; mineral food supplements; preparations of trace elements for human and animal use, namely, dietary supplements; vitamin preparations; animal feed supplements, not for medical purposes; animal feed supplements in form of amino acids, peptides and proteins for animal feed, fish food and aquacultures; animal feed supplements, namely, non-medicated additives for animal feed for use as nutritional supplements; probiotic supplements; probiotic animal feed; nutritional supplements, namely, probiotic compositions; micro-nutrient animal feed for fish and aquacultures; feed supplements, namely, synthetic peptides for the treatment of nutrition deficiencies; protein supplements for animals; amino acids and peptides for nutritional purposes for use in animal feed, fish food and aquaculture; feed supplements containing Enterococcus faeciumSECTION 71 - CANCELLED—
031Agricultural, horticultural and forestry products as well as products for aquaculture, namely, aquaculture feed; live animals; organisms for breeding, namely, live animals; foodstuffs and fodder for animals; bedding for animals, namely, chopped straw for animal bedding, cellulose for use as animal bedding, and litter for animals; animal feed preparations; nutrients foodstuffs for fish and aquacultures, namely, aquaculture feed, foodstuffs for fish; yeast for animal consumptionSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 5, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 5, 2025C71TCANCELLED SECTION 71—
May 21, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 5, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 27, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 10, 2019FIMPFINAL DISPOSITION PROCESSED—
Aug 21, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 21, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 17, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 1, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 1, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2019GPNXNOTIFICATION PROCESSED BY IB—
Feb 13, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 13, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2018ALIEASSIGNED TO LIE—
Jun 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 27, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 27, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 13, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 8, 2017DOCKASSIGNED TO EXAMINER—
Dec 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance